Vétoquinol Publishes Its Registration Document and Its Annual Financial Report Relative to Fiscal Year 2012 (French Version)

Regulatory News:

The registration document of Vétoquinol (Paris:VETO) relative to fiscal year 2012, including the annual financial report relative to fiscal year 2012, was registered with the Autorité des marchés financiers ("the AMF”) on April 15^th, 2013.

It can be read or downloaded on the websites of:

• Vétoquinol (www.vetoquinol.com)
• the AMF (www.amf-france.org)

It is also available to the public free of charge upon simple request:

• by mail: Vétoquinol
  Communication financière
  Magny-Vernois – BP 189 – 70204 Lure Cedex - France

• by e-mail: relations.investisseurs@vetoquinol.com
• by phone: +33 (0)3 84 62 59 88

The registration document integrates among other:

• the report of the President of the Supervisory Board of Vétoquinol established upon provisions of article L. 225-68 of the French Commercial code;
• the statutory auditors' reports;
• the information relative to the fees paid to the statutory auditors.

About Vétoquinol
Vétoquinol is a leading global operator in the animal health sector, serving both the livestock (cattle and pigs) and pet (dogs and cats) markets.
An independent pure player, Vétoquinol designs, develops and markets veterinary drugs and non-medicinal products in Europe, the Americas and the Asia Pacific region.
Since its foundation in 1933, Vétoquinol has pursued a strategy combining innovation with geographical diversification. The Group's hybrid growth is driven by the reinforcement of its product portfolio coupled with acquisitions in high potential growth markets. Vétoquinol has over 1,800 employees.
Vétoquinol has been listed on NYSE Euronext Paris since 2006 (symbol: VETO).

For more information: www.vetoquinol.com.

OUR BUSINESS: ANIMALS. OUR ADVANTAGE: PEOPLE.

VETOQUINOL – 34 rue du Chêne Sainte Anne - Magny-Vernois – 70204 Lure Cedex – France